Industry Research Reports
Home > Reports > Service & Software > Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Service & Software
Published Date: 2026-03-31
Pages: 105 Pages
Report ld: 6390002
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Virtual Screening for Drug Discovery market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
In 2025, the North America Virtual Screening for Drug Discovery market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Virtual Screening for Drug Discovery include MedChemExpress, TargetMol, OpenEye Scientific, Eurofins Discovery, Sygnature Discovery, Jubilant Biosys, Schrödinger, Inc., Cresset Group, ComputaBio, Profacgen, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Virtual Screening for Drug Discovery market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- MedChemExpress
- TargetMol
- OpenEye Scientific
- Eurofins Discovery
- Sygnature Discovery
- Jubilant Biosys
- Schrödinger, Inc.
- Cresset Group
- ComputaBio
- Profacgen
- CD ComputaBio
- Creative Biolabs
- BOC Sciences
- CKTTDB
- HitGen
- WuXi AppTec
- LeadBuilder
- CSNpharm
- ChemNavigator
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Structure-based Virtual Screening (SBVS)
- Ligand-based Virtual Screening (LBVS)
- Hybrid Methods
Segment by Application
- Pharmaceutical Company
- Universities and Research Institutions
- Others
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Virtual Screening for Drug Discovery value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Structure-based Virtual Screening (SBVS)
1.2.3 Ligand-based Virtual Screening (LBVS)
1.2.4 Hybrid Methods
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Company
1.3.3 Universities and Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Virtual Screening for Drug Discovery Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Virtual Screening for Drug Discovery Market Share by Revenue, by Region (2021-2026)
2.4 Global Virtual Screening for Drug Discovery Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Virtual Screening for Drug Discovery Market Size and Prospective (2021-2032)
2.5.2 Europe Virtual Screening for Drug Discovery Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Virtual Screening for Drug Discovery Market Size and Prospective (2021-2032)
2.5.4 Latin America Virtual Screening for Drug Discovery Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Virtual Screening for Drug Discovery Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Virtual Screening for Drug Discovery Historical Market Size by Type (2021-2026)
3.2 Global Virtual Screening for Drug Discovery Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Virtual Screening for Drug Discovery
4 Breakdown Data by Application
4.1 Global Virtual Screening for Drug Discovery Historical Market Size by Application (2021-2026)
4.2 Global Virtual Screening for Drug Discovery Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Virtual Screening for Drug Discovery Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Virtual Screening for Drug Discovery Players by Revenue (2021-2026)
5.1.2 Global Virtual Screening for Drug Discovery Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Virtual Screening for Drug Discovery Revenue
5.4 Global Virtual Screening for Drug Discovery Market Concentration Analysis
5.4.1 Global Virtual Screening for Drug Discovery Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Virtual Screening for Drug Discovery Revenue in 2025
5.5 Global Key Players of Virtual Screening for Drug Discovery Head Offices and Areas Served
5.6 Global Key Players of Virtual Screening for Drug Discovery, Product and Application
5.7 Global Key Players of Virtual Screening for Drug Discovery, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Virtual Screening for Drug Discovery Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Virtual Screening for Drug Discovery Market Size by Type (2021-2026)
6.1.2.2 North America Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Virtual Screening for Drug Discovery Market Size by Application (2021-2026)
6.1.3.2 North America Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
6.1.4 North America Virtual Screening for Drug Discovery Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Virtual Screening for Drug Discovery Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Virtual Screening for Drug Discovery Market Size by Type (2021-2026)
6.2.2.2 Europe Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Virtual Screening for Drug Discovery Market Size by Application (2021-2026)
6.2.3.2 Europe Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
6.2.4 Europe Virtual Screening for Drug Discovery Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Virtual Screening for Drug Discovery Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Virtual Screening for Drug Discovery Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Virtual Screening for Drug Discovery Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Virtual Screening for Drug Discovery Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Virtual Screening for Drug Discovery Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Virtual Screening for Drug Discovery Market Size by Type (2021-2026)
6.4.2.2 Latin America Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Virtual Screening for Drug Discovery Market Size by Application (2021-2026)
6.4.3.2 Latin America Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
6.4.4 Latin America Virtual Screening for Drug Discovery Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Virtual Screening for Drug Discovery Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Virtual Screening for Drug Discovery Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Virtual Screening for Drug Discovery Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Virtual Screening for Drug Discovery Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 MedChemExpress
7.1.1 MedChemExpress Company Details
7.1.2 MedChemExpress Business Overview
7.1.3 MedChemExpress Virtual Screening for Drug Discovery Introduction
7.1.4 MedChemExpress Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.1.5 MedChemExpress Recent Development
7.2 TargetMol
7.2.1 TargetMol Company Details
7.2.2 TargetMol Business Overview
7.2.3 TargetMol Virtual Screening for Drug Discovery Introduction
7.2.4 TargetMol Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.2.5 TargetMol Recent Development
7.3 OpenEye Scientific
7.3.1 OpenEye Scientific Company Details
7.3.2 OpenEye Scientific Business Overview
7.3.3 OpenEye Scientific Virtual Screening for Drug Discovery Introduction
7.3.4 OpenEye Scientific Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.3.5 OpenEye Scientific Recent Development
7.4 Eurofins Discovery
7.4.1 Eurofins Discovery Company Details
7.4.2 Eurofins Discovery Business Overview
7.4.3 Eurofins Discovery Virtual Screening for Drug Discovery Introduction
7.4.4 Eurofins Discovery Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.4.5 Eurofins Discovery Recent Development
7.5 Sygnature Discovery
7.5.1 Sygnature Discovery Company Details
7.5.2 Sygnature Discovery Business Overview
7.5.3 Sygnature Discovery Virtual Screening for Drug Discovery Introduction
7.5.4 Sygnature Discovery Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.5.5 Sygnature Discovery Recent Development
7.6 Jubilant Biosys
7.6.1 Jubilant Biosys Company Details
7.6.2 Jubilant Biosys Business Overview
7.6.3 Jubilant Biosys Virtual Screening for Drug Discovery Introduction
7.6.4 Jubilant Biosys Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.6.5 Jubilant Biosys Recent Development
7.7 Schrödinger, Inc.
7.7.1 Schrödinger, Inc. Company Details
7.7.2 Schrödinger, Inc. Business Overview
7.7.3 Schrödinger, Inc. Virtual Screening for Drug Discovery Introduction
7.7.4 Schrödinger, Inc. Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.7.5 Schrödinger, Inc. Recent Development
7.8 Cresset Group
7.8.1 Cresset Group Company Details
7.8.2 Cresset Group Business Overview
7.8.3 Cresset Group Virtual Screening for Drug Discovery Introduction
7.8.4 Cresset Group Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.8.5 Cresset Group Recent Development
7.9 ComputaBio
7.9.1 ComputaBio Company Details
7.9.2 ComputaBio Business Overview
7.9.3 ComputaBio Virtual Screening for Drug Discovery Introduction
7.9.4 ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.9.5 ComputaBio Recent Development
7.10 Profacgen
7.10.1 Profacgen Company Details
7.10.2 Profacgen Business Overview
7.10.3 Profacgen Virtual Screening for Drug Discovery Introduction
7.10.4 Profacgen Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.10.5 Profacgen Recent Development
7.11 CD ComputaBio
7.11.1 CD ComputaBio Company Details
7.11.2 CD ComputaBio Business Overview
7.11.3 CD ComputaBio Virtual Screening for Drug Discovery Introduction
7.11.4 CD ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.11.5 CD ComputaBio Recent Development
7.12 Creative Biolabs
7.12.1 Creative Biolabs Company Details
7.12.2 Creative Biolabs Business Overview
7.12.3 Creative Biolabs Virtual Screening for Drug Discovery Introduction
7.12.4 Creative Biolabs Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.12.5 Creative Biolabs Recent Development
7.13 BOC Sciences
7.13.1 BOC Sciences Company Details
7.13.2 BOC Sciences Business Overview
7.13.3 BOC Sciences Virtual Screening for Drug Discovery Introduction
7.13.4 BOC Sciences Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.13.5 BOC Sciences Recent Development
7.14 CKTTDB
7.14.1 CKTTDB Company Details
7.14.2 CKTTDB Business Overview
7.14.3 CKTTDB Virtual Screening for Drug Discovery Introduction
7.14.4 CKTTDB Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.14.5 CKTTDB Recent Development
7.15 HitGen
7.15.1 HitGen Company Details
7.15.2 HitGen Business Overview
7.15.3 HitGen Virtual Screening for Drug Discovery Introduction
7.15.4 HitGen Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.15.5 HitGen Recent Development
7.16 WuXi AppTec
7.16.1 WuXi AppTec Company Details
7.16.2 WuXi AppTec Business Overview
7.16.3 WuXi AppTec Virtual Screening for Drug Discovery Introduction
7.16.4 WuXi AppTec Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.16.5 WuXi AppTec Recent Development
7.17 LeadBuilder
7.17.1 LeadBuilder Company Details
7.17.2 LeadBuilder Business Overview
7.17.3 LeadBuilder Virtual Screening for Drug Discovery Introduction
7.17.4 LeadBuilder Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.17.5 LeadBuilder Recent Development
7.18 CSNpharm
7.18.1 CSNpharm Company Details
7.18.2 CSNpharm Business Overview
7.18.3 CSNpharm Virtual Screening for Drug Discovery Introduction
7.18.4 CSNpharm Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.18.5 CSNpharm Recent Development
7.19 ChemNavigator
7.19.1 ChemNavigator Company Details
7.19.2 ChemNavigator Business Overview
7.19.3 ChemNavigator Virtual Screening for Drug Discovery Introduction
7.19.4 ChemNavigator Revenue in Virtual Screening for Drug Discovery Business (2021-2026)
7.19.5 ChemNavigator Recent Development
8 Virtual Screening for Drug Discovery Market Dynamics
8.1 Virtual Screening for Drug Discovery Industry Trends
8.2 Virtual Screening for Drug Discovery Market Drivers
8.3 Virtual Screening for Drug Discovery Market Challenges
8.4 Virtual Screening for Drug Discovery Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Virtual Screening for Drug Discovery Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Virtual Screening for Drug Discovery Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Virtual Screening for Drug Discovery Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Virtual Screening for Drug Discovery Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Virtual Screening for Drug Discovery Revenue Share by Region (2021-2026)
Table 6. Global Virtual Screening for Drug Discovery Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Virtual Screening for Drug Discovery Revenue Share Forecast by Region (2027-2032)
Table 8. Global Virtual Screening for Drug Discovery Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Virtual Screening for Drug Discovery Market Share by Revenue, by Type (2021-2026)
Table 10. Global Virtual Screening for Drug Discovery Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Virtual Screening for Drug Discovery Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Virtual Screening for Drug Discovery Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Virtual Screening for Drug Discovery Market Share by Revenue, by Application (2021-2026)
Table 15. Global Virtual Screening for Drug Discovery Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Virtual Screening for Drug Discovery Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Virtual Screening for Drug Discovery Applications
Table 18. Global Virtual Screening for Drug Discovery Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Virtual Screening for Drug Discovery Market Share by Players (2021-2026)
Table 20. Global Top Virtual Screening for Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Screening for Drug Discovery as of 2025)
Table 21. Ranking of Global Top Virtual Screening for Drug Discovery Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Virtual Screening for Drug Discovery Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Virtual Screening for Drug Discovery, Headquarters and Area Served
Table 24. Global Key Players of Virtual Screening for Drug Discovery, Product and Application
Table 25. Global Key Players of Virtual Screening for Drug Discovery, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Virtual Screening for Drug Discovery Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Virtual Screening for Drug Discovery Market Share by Revenue, by Company (2021-2026)
Table 29. North America Virtual Screening for Drug Discovery Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Virtual Screening for Drug Discovery Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Virtual Screening for Drug Discovery Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Virtual Screening for Drug Discovery Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Virtual Screening for Drug Discovery Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Virtual Screening for Drug Discovery Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Virtual Screening for Drug Discovery Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Virtual Screening for Drug Discovery Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Virtual Screening for Drug Discovery Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Virtual Screening for Drug Discovery Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Virtual Screening for Drug Discovery Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Virtual Screening for Drug Discovery Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Virtual Screening for Drug Discovery Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Virtual Screening for Drug Discovery Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Virtual Screening for Drug Discovery Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Virtual Screening for Drug Discovery Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Virtual Screening for Drug Discovery Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Virtual Screening for Drug Discovery Market Size by Application (2021-2026) & (US$ Million)
Table 47. MedChemExpress Company Details
Table 48. MedChemExpress Business Overview
Table 49. MedChemExpress Virtual Screening for Drug Discovery Product
Table 50. MedChemExpress Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 51. MedChemExpress Recent Development
Table 52. TargetMol Company Details
Table 53. TargetMol Business Overview
Table 54. TargetMol Virtual Screening for Drug Discovery Product
Table 55. TargetMol Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 56. TargetMol Recent Development
Table 57. OpenEye Scientific Company Details
Table 58. OpenEye Scientific Business Overview
Table 59. OpenEye Scientific Virtual Screening for Drug Discovery Product
Table 60. OpenEye Scientific Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 61. OpenEye Scientific Recent Development
Table 62. Eurofins Discovery Company Details
Table 63. Eurofins Discovery Business Overview
Table 64. Eurofins Discovery Virtual Screening for Drug Discovery Product
Table 65. Eurofins Discovery Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 66. Eurofins Discovery Recent Development
Table 67. Sygnature Discovery Company Details
Table 68. Sygnature Discovery Business Overview
Table 69. Sygnature Discovery Virtual Screening for Drug Discovery Product
Table 70. Sygnature Discovery Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 71. Sygnature Discovery Recent Development
Table 72. Jubilant Biosys Company Details
Table 73. Jubilant Biosys Business Overview
Table 74. Jubilant Biosys Virtual Screening for Drug Discovery Product
Table 75. Jubilant Biosys Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 76. Jubilant Biosys Recent Development
Table 77. Schrödinger, Inc. Company Details
Table 78. Schrödinger, Inc. Business Overview
Table 79. Schrödinger, Inc. Virtual Screening for Drug Discovery Product
Table 80. Schrödinger, Inc. Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 81. Schrödinger, Inc. Recent Development
Table 82. Cresset Group Company Details
Table 83. Cresset Group Business Overview
Table 84. Cresset Group Virtual Screening for Drug Discovery Product
Table 85. Cresset Group Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 86. Cresset Group Recent Development
Table 87. ComputaBio Company Details
Table 88. ComputaBio Business Overview
Table 89. ComputaBio Virtual Screening for Drug Discovery Product
Table 90. ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 91. ComputaBio Recent Development
Table 92. Profacgen Company Details
Table 93. Profacgen Business Overview
Table 94. Profacgen Virtual Screening for Drug Discovery Product
Table 95. Profacgen Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 96. Profacgen Recent Development
Table 97. CD ComputaBio Company Details
Table 98. CD ComputaBio Business Overview
Table 99. CD ComputaBio Virtual Screening for Drug Discovery Product
Table 100. CD ComputaBio Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 101. CD ComputaBio Recent Development
Table 102. Creative Biolabs Company Details
Table 103. Creative Biolabs Business Overview
Table 104. Creative Biolabs Virtual Screening for Drug Discovery Product
Table 105. Creative Biolabs Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 106. Creative Biolabs Recent Development
Table 107. BOC Sciences Company Details
Table 108. BOC Sciences Business Overview
Table 109. BOC Sciences Virtual Screening for Drug Discovery Product
Table 110. BOC Sciences Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 111. BOC Sciences Recent Development
Table 112. CKTTDB Company Details
Table 113. CKTTDB Business Overview
Table 114. CKTTDB Virtual Screening for Drug Discovery Product
Table 115. CKTTDB Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 116. CKTTDB Recent Development
Table 117. HitGen Company Details
Table 118. HitGen Business Overview
Table 119. HitGen Virtual Screening for Drug Discovery Product
Table 120. HitGen Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 121. HitGen Recent Development
Table 122. WuXi AppTec Company Details
Table 123. WuXi AppTec Business Overview
Table 124. WuXi AppTec Virtual Screening for Drug Discovery Product
Table 125. WuXi AppTec Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 126. WuXi AppTec Recent Development
Table 127. LeadBuilder Company Details
Table 128. LeadBuilder Business Overview
Table 129. LeadBuilder Virtual Screening for Drug Discovery Product
Table 130. LeadBuilder Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 131. LeadBuilder Recent Development
Table 132. CSNpharm Company Details
Table 133. CSNpharm Business Overview
Table 134. CSNpharm Virtual Screening for Drug Discovery Product
Table 135. CSNpharm Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 136. CSNpharm Recent Development
Table 137. ChemNavigator Company Details
Table 138. ChemNavigator Business Overview
Table 139. ChemNavigator Virtual Screening for Drug Discovery Product
Table 140. ChemNavigator Revenue in Virtual Screening for Drug Discovery Business (2021-2026) & (US$ Million)
Table 141. ChemNavigator Recent Development
Table 142. Virtual Screening for Drug Discovery Market Trends
Table 143. Virtual Screening for Drug Discovery Market Drivers
Table 144. Virtual Screening for Drug Discovery Market Challenges
Table 145. Virtual Screening for Drug Discovery Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Virtual Screening for Drug Discovery Product Picture
Figure 2. Global Virtual Screening for Drug Discovery Market Share by Type: 2025 vs 2032
Figure 3. Structure-based Virtual Screening (SBVS) Features
Figure 4. Ligand-based Virtual Screening (LBVS) Features
Figure 5. Hybrid Methods Features
Figure 6. Global Virtual Screening for Drug Discovery Market Share by Application: 2025 vs 2032
Figure 7. Pharmaceutical Company
Figure 8. Universities and Research Institutions
Figure 9. Others
Figure 10. Virtual Screening for Drug Discovery Report Years Considered
Figure 11. Global Virtual Screening for Drug Discovery Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global Virtual Screening for Drug Discovery Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Virtual Screening for Drug Discovery Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America Virtual Screening for Drug Discovery Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe Virtual Screening for Drug Discovery Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Asia-Pacific Virtual Screening for Drug Discovery Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Latin America Virtual Screening for Drug Discovery Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Middle East & Africa Virtual Screening for Drug Discovery Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global Virtual Screening for Drug Discovery Market Share by Players in 2025
Figure 20. Global Top Virtual Screening for Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virtual Screening for Drug Discovery as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by Virtual Screening for Drug Discovery Revenue in 2025
Figure 22. North America Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
Figure 23. North America Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
Figure 24. Europe Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
Figure 25. Europe Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
Figure 26. Asia-Pacific Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
Figure 27. Asia-Pacific Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
Figure 28. Latin America Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
Figure 29. Latin America Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
Figure 30. Middle East & Africa Virtual Screening for Drug Discovery Market Share by Type (2021-2026)
Figure 31. Middle East & Africa Virtual Screening for Drug Discovery Market Share by Application (2021-2026)
Figure 32. MedChemExpress Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 33. TargetMol Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 34. OpenEye Scientific Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 35. Eurofins Discovery Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 36. Sygnature Discovery Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 37. Jubilant Biosys Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 38. Schrödinger, Inc. Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 39. Cresset Group Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 40. ComputaBio Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 41. Profacgen Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 42. CD ComputaBio Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 43. Creative Biolabs Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 44. BOC Sciences Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 45. CKTTDB Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 46. HitGen Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 47. WuXi AppTec Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 48. LeadBuilder Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 49. CSNpharm Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 50. ChemNavigator Revenue Growth Rate in Virtual Screening for Drug Discovery Business (2021-2026)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Virtual Screening for Drug Discovery market?
The top companies in the global Virtual Screening for Drug Discovery market are MedChemExpress、TargetMol、OpenEye Scientific.
Related Reports
Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 160
USD 4900.00
(Single User License)
Virtual Screening for Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 139
USD 3950.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2026
The global Virtual Screening for Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 127
USD 2900.00
(Single User License)
Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Virtual Screening for Drug Discovery market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 105
USD 4250.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 156
USD 4900.00
(Single User License)
Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 121
USD 3950.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2025
The global market for Virtual Screening for Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 99
USD 2900.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Research Report 2024
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published Date: 2024-04-28
Pages: 95
USD 2900.00
(Single User License)
Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published Date: 2024-04-28
Pages: 138
USD 3950.00
(Single User License)
Global and United States Virtual Screening for Drug Discovery Market Report & Forecast 2024-2030
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published Date: 2024-04-28
Pages: 121
USD 4350.00
(Single User License)
Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 160
USD 4900.00 (Single User License)Virtual Screening for Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 139
USD 3950.00 (Single User License)Global Virtual Screening for Drug Discovery Market Research Report 2026
The global Virtual Screening for Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 127
USD 2900.00 (Single User License)Global Virtual Screening for Drug Discovery Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Virtual Screening for Drug Discovery market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 105
USD 4250.00 (Single User License)Global Virtual Screening for Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Virtual Screening for Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 156
USD 4900.00 (Single User License)Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Virtual Screening for Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 121
USD 3950.00 (Single User License)Global Virtual Screening for Drug Discovery Market Research Report 2025
The global market for Virtual Screening for Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 99
USD 2900.00 (Single User License)Global Virtual Screening for Drug Discovery Market Research Report 2024
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published: 2024-04-28
Pages: 95
USD 2900.00 (Single User License)Virtual Screening for Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published: 2024-04-28
Pages: 138
USD 3950.00 (Single User License)Global and United States Virtual Screening for Drug Discovery Market Report & Forecast 2024-2030
Virtual screening (VS) is a computational technique used in drug discovery to search libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme.
Published: 2024-04-28
Pages: 121
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now